Pandion Therapeutics (Acquired by Merck)
Biotechnology company that developed targeted immunotherapies for autoimmune diseases using tissue-specific Treg modulators. Acquired by Merck in 2021 for $1.85 billion.
Location
Watertown, Massachusetts, USA
Founded
2016
Investors
1
Categories
biotech, autoimmune, immunotherapy, acquired
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Polaris Partners | US | biotech-focused | - | 33 |
